Ohio Public Employees Retirement System (OPERS)’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
Ohio Public Employees Retirement System (OPERS)'s SMMT Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) increased its Summit Therapeutics (SMMT) stake by 13% in Q2 2026, buying an estimated $79.8K and bringing the position to 38,501 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.
Ohio Public Employees Retirement System (OPERS) first reported a position in SMMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $772K in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) held 38,501 shares of Summit Therapeutics worth $561K as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) bought 4,502 Summit Therapeutics shares in Q2 2026, an estimated $79.8K.
- Summit Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1467 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Summit Therapeutics in Q2 2025 and has held it in 5 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Summit Therapeutics position peaked at $772K in Q2 2025.
- 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.